Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 9, 2017 - Issue
Submit an article Journal homepage
48
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial

Umberto Restelli1 Center for Health Economics, Social and Health Care Management, LIUC – Università Cattaneo, Castellanza, Italy;2 School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaCorrespondence[email protected]
,
Massimiliano Fabbiani3 Institute of Clinical Infectious Diseases, Catholic University of Sacred Heart
,
Simona Di Giambenedetto3 Institute of Clinical Infectious Diseases, Catholic University of Sacred Heart
,
Carmela Nappi4 Health Economics, Bristol Myers Squibb S.r.l., Rome, Italy
&
Davide Croce1 Center for Health Economics, Social and Health Care Management, LIUC – Università Cattaneo, Castellanza, Italy;2 School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Pages 569-571 | Published online: 27 Sep 2017

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.